CN104187725A - 一种调理大肠肿瘤的方便食品 - Google Patents
一种调理大肠肿瘤的方便食品 Download PDFInfo
- Publication number
- CN104187725A CN104187725A CN201410417229.5A CN201410417229A CN104187725A CN 104187725 A CN104187725 A CN 104187725A CN 201410417229 A CN201410417229 A CN 201410417229A CN 104187725 A CN104187725 A CN 104187725A
- Authority
- CN
- China
- Prior art keywords
- food
- vitamin
- conditioning
- medicine
- colorectal cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 65
- 208000001333 Colorectal Neoplasms Diseases 0.000 title claims abstract description 27
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 38
- 239000003814 drug Substances 0.000 claims abstract description 28
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 21
- 239000011707 mineral Substances 0.000 claims abstract description 21
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 20
- 235000003230 Helianthus tuberosus Nutrition 0.000 claims abstract description 19
- 240000008892 Helianthus tuberosus Species 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 17
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 17
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 17
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 17
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 12
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 11
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 11
- 244000189799 Asimina triloba Species 0.000 claims abstract description 10
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 10
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 10
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 10
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 10
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 10
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 10
- 240000007651 Rubus glaucus Species 0.000 claims abstract description 10
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 10
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 8
- 229930003231 vitamin Natural products 0.000 claims abstract description 8
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011782 vitamin Substances 0.000 claims abstract description 8
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 6
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 28
- 206010009944 Colon cancer Diseases 0.000 claims description 20
- 239000000284 extract Substances 0.000 claims description 20
- 241000287828 Gallus gallus Species 0.000 claims description 17
- 210000004317 gizzard Anatomy 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 16
- 229940024606 amino acid Drugs 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 13
- 239000001702 nutmeg Substances 0.000 claims description 13
- 235000006487 Euryale ferox Nutrition 0.000 claims description 12
- 244000268590 Euryale ferox Species 0.000 claims description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 12
- 244000077995 Coix lacryma jobi Species 0.000 claims description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 240000004307 Citrus medica Species 0.000 claims description 10
- 235000001938 Citrus medica Nutrition 0.000 claims description 10
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims description 10
- 241001264174 Cordyceps militaris Species 0.000 claims description 10
- 240000004638 Dendrobium nobile Species 0.000 claims description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 10
- 244000241838 Lycium barbarum Species 0.000 claims description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- 244000197580 Poria cocos Species 0.000 claims description 10
- 235000008599 Poria cocos Nutrition 0.000 claims description 10
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 10
- 241000245665 Taraxacum Species 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 10
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 8
- 244000144725 Amygdalus communis Species 0.000 claims description 7
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 235000020224 almond Nutrition 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- 235000007215 black sesame Nutrition 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 5
- 235000020958 biotin Nutrition 0.000 claims description 5
- 239000011616 biotin Substances 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011651 chromium Substances 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 229910052750 molybdenum Inorganic materials 0.000 claims description 5
- 239000011733 molybdenum Substances 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims description 5
- 239000011713 pantothenic acid Substances 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 235000019175 phylloquinone Nutrition 0.000 claims description 5
- 239000011772 phylloquinone Substances 0.000 claims description 5
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 5
- 229960001898 phytomenadione Drugs 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 235000008151 pyridoxamine Nutrition 0.000 claims description 5
- 239000011699 pyridoxamine Substances 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- -1 citrulling Chemical compound 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 239000011572 manganese Substances 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 230000000474 nursing effect Effects 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 244000098338 Triticum aestivum Species 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 229940001941 soy protein Drugs 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- 244000270834 Myristica fragrans Species 0.000 claims 4
- 244000088415 Raphanus sativus Species 0.000 claims 3
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- 235000005911 diet Nutrition 0.000 abstract description 4
- 238000001959 radiotherapy Methods 0.000 abstract description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract description 3
- 238000002512 chemotherapy Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 239000012676 herbal extract Substances 0.000 abstract 3
- 210000000582 semen Anatomy 0.000 abstract 2
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 244000025361 Ficus carica Species 0.000 abstract 1
- 235000008730 Ficus carica Nutrition 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 229930182816 L-glutamine Natural products 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 12
- 210000004379 membrane Anatomy 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 241000498779 Myristica Species 0.000 description 9
- 230000035622 drinking Effects 0.000 description 9
- 235000008216 herbs Nutrition 0.000 description 9
- 230000010354 integration Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241000220259 Raphanus Species 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 241000209205 Coix Species 0.000 description 3
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000016236 parenteral nutrition Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241001647745 Banksia Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 201000002758 colorectal adenoma Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供了调理大肠肿瘤的方便食品,该产品以L-谷氨酰胺为主要原料,根据大肠肿瘤患者的体质特征,用传统中医精髓理论,有针对性的合理配伍:石斛、薏苡仁、菊芋、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、木瓜、杏仁、覆盆子、马齿苋、砂仁等药食两用中草药提取物经生物酶解或预水解SBE技术提取,再添加益生元、氨基酸、短肽、维生素和矿物质混合制成。按照本发明配方制备的食品,易溶解,可快速吸收和利用,改善大肠肿瘤患者的营养状况,通过药食两用中草药提取物中的生物活性成分的作用,可以辅助提高机体免疫力,起到抑癌、抗癌作用,适合大肠肿瘤患者尤其是接受放疗或化疗的癌症病人食用,因此具有集食疗、预防、调理三重功效于一体的独特优势。
Description
技术领域
本发明属于药食同源类配方食品技术领域,将现代生物科技研究成果、现代营养学理论及“药食同源之中药”的传统中医精髓理论相结合,是一种调理大肠肿瘤的方便食品。
背景技术
大肠癌是常见的恶性肿瘤之一,包括直肠癌、结肠癌等表现,是影响人们身体健康的重要疾病之一,大肠癌临床上往往见病程迁延难愈,证候错综复杂,寒热虚实兼夹,大肠癌为结肠癌和直肠癌的总称,大肠癌是指大肠粘膜上皮在环境或遗传等多种致癌因素作用下发生的恶性病变预后不良,死亡率较高,大肠癌是大肠粘膜上皮起源的恶性肿瘤,是最常见的消化道恶性肿瘤之一,大肠癌成因:大肠癌的发生与高脂肪低纤维素饮食、大肠慢性炎症、大肠腺瘤、遗传因素和其他因素如:血吸虫病、盆腔放射、环境因素、吸烟等有关,而肠道微生物失衡引起IBD 是诱发肠道癌症的重要因子;2012年权威杂志Science发表了一项研究结果,发现肠道炎症是癌症的一个风险因子——提出这可能是因为炎症扰乱了肠道微生态系统,使病原体能够入侵肠道,损害宿主细胞从而提高结肠癌的风险;因此,如何调控肠道菌群比例,降低有害菌群、提高有益肠道菌群比例是控制肠道关联疾病之核心,近几年临床应用研究表明,补充益生菌能平衡肠道菌群、在抑制肠道慢性炎症的作用是明显的,且益生菌作为一种安全、有效的治疗方法,临床可以应用于治疗IBD,但是,目前应用存在着的主要难题是:益生菌通过直接口服由于在肠内无法有效定植,且停留、占位很少,易流失,停服后有害菌易复发,相关患者需要长期服药,治疗周期长;因此,如何有效的提高外源益生菌或内源有益菌群在肠道中的定植是目前面临的重要理论难题,针对这个核心的技术难题,本公司团队以促益生菌肠道定植的机理为基础,以益生元、肠道收敛、降低肠道pH环境等为主要筛选要素,以肠道细胞模型为研究对象,进行了大量的前期筛选和配比试验,从数十种药食同源中药中首次筛选出了对外源益生菌在肠道中定植具有促进作用的食材——薏苡仁、山药、鸡内金、芡实和菊芋,等为肠道微生态制剂中益生菌的复方选择提供依据,大量实验证明,薏米中薏米酯、薏八醇及β、γ2种谷甾醇等具有防癌、抗癌作用,由薏米为原料生产的薏米黄酒经研究表明,服用薏米黄酒的小鼠肠道内乳酸菌数高于对照组且有显著统计学意义(P<0.01),真菌数量低于对照组有统计学意义(P<0.05),山药是传统补益中药材,含有多种对人体有益的营养物质和活性成分,对机体功能存在广泛的影响,有健脾养胃、补肺益肾、止泻利湿之功效;山药能抑制肠管推进运动,其含有的淀粉酶有助于消化作用,芡实常用作滋补品,其化学成分可分为营养成分和功效成分两类,营养成分主要为碳水化合物和蛋白质,功效成分包括黄酮类、环肽类、甾醇类、脂类、脑苷脂类等,具有益肾固精、补脾止泻、袪湿止带的功效,鲜菊芋块茎中含有16.6%的粗纤维,碳水化合物的78%为菊糖,菊糖有许多生理功能,最为突出的是其含有丰富的双歧因子,能够调整肠道内的微生物区系组成和功能,尤其是能选择性促进双歧杆菌等有益菌的生长,鸡内金是雉科动物家鸡的干燥砂囊角质内壁,具有健胃消食的功效,主要含有胃激素、角蛋白、氨基酸等成分,鸡内金能剂量依赖性的加速肠道的蠕动,通过加速小肠的推进运动,从而促进肠道食物残渣的排空速度,减少其在肠内的停留时间;
大肠肿瘤临床上更多地采用肠外营养(即输入营养药)的方式对癌症患者进行营养补充,长期的肠外营养补充易造成肠道绒毛萎缩,以及并发感染,从而加重对机体的危害;因此,国内外临床营养学界一致认为,制备易于消化吸收的特殊营养食品,并通过肠内途径对癌症患者进行营养补充,是一种更加适宜的方法,对于特殊营养食品,在美国、欧盟等发达国家都有相应的规定和开发应用;所谓“特殊膳食用食品”,在我国的《预包装特殊膳食用食品标签通则》(GB13432-2004)中规定,是为满足某些特殊人群的生理需要,或某些疾病患者的营养需要,按特殊配方而专门加工的食品;
“药食同源”是中华原创医学之中对人类最有价值的贡献之一,这是中华原创医学选择食品最主要的标准,这个标准是建立在“以人为本”的基础上的,中医历来强调“药疗不如食疗”,食疗成为现代人追求返璞归真、健康饮食的最佳选择,现代营养学和药理学研究已经证实,药食两用中草药中所含有活性多糖类、皂苷类、酚类等生理活性成分对机体生理功能具有重要的调节作用;以食物为药物具有以下几大突出的优点:一、长期使用药物治病往往会产生各种副作用和依赖性,而且还可能对人体的健康造成影响,而食疗相对安全有效,毒副作用小;二、食疗使用都是我们日常生活中常见的食物,价格低廉,让我们在日常用餐中便可达到调理的目的,这是昂贵的医药费所无法比拟的;三、食物为药还具有无痛苦的优点,让人们在享受美食的过程中祛除病痛,避免了打针、吃药,甚至手术之苦;
本人把“药食同源”与“新资源食品”的中药完美结合,将饮食与养生有机结合,以调理预防抵御肿瘤,本发明属于药食同源及新资源类配方方便食品技术领域,具体是一种适用于肿瘤患者食用的方便食品,在继承中医精髓理论治病方法上,根据大肠肿瘤体质特征,添加菊芋、薏苡仁、桃仁、甘草、金银花、鸡内金、木香、沙棘、佛手、莱菔子、香菇、陈皮、枸杞、山药、茯苓、黄精多种药食同源食材的提取物,起到清热解毒、活血化瘀、理气化浊、降逆止呕及抗癌和抑癌的功效,同时也能满足肿瘤患者的营养需要,增强免疫功能,提高肿瘤患者对手术、放疗、化疗的耐受力,长期食用可以改善恶性肿瘤放疗患者的伴随症状,达到扶正培本、扶正祛邪,改善症状,提高患者免疫力和延长生存期的目的,是一种适合于恶性肿瘤及放疗患者非治疗目的方便食品。
发明目的
本发明的目的是提供一种在继承中医精髓理论治病方法上,采用 “药食同源之中药”复方的提取物,具有毒副作用小、安全有效,价格低廉的特点,且人们容易接受的调理大肠肿瘤的方便食品。
发明内容
本人把“药食同源”与“新资源食品”的中药完美结合,结合大肠癌患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果,依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用7种以上药食两用的中药提取物精华、短肽为主要原料,以益生元、氨基酸、多种维生素及矿物质辅料,不仅可作为单一营养来源满足大肠癌患者的营养需求,还有起到行气散结、消积化瘀、利水消肿、清热解毒、理气化浊、降逆止呕以及增强免疫力的功效的方便食品。
1、本发明配方的主要的主要成分:
中药提取物是根据大肠癌患者的体质特征从中医理论中的肝、脾、肾三脏同调为主原则,利用药食两用中草药中的功能因子调节机体功能增强抵抗力,并选取以下几大类药物进行配伍;其中:石斛具有生津养胃,滋阴清热,润肺益肾,明目强腰的功效,冬虫夏草性温;归肺、肾经;温和滋补,可升可降;具有补肺气,益肾精的功效,蛹虫草补虚损、益精气、保肺、益肾、止血化痰、滋补强壮等功效,菊芋有利水除湿,清热凉血,和中益胃的作用,芡实有固肾涩精,补脾止泄,利水渗湿的作用,马齿苋有清热解毒、祛湿止带功效,茯苓具有渗湿利水,健脾和胃,宁心安神的功效,金银花清热解毒,凉散风热的作用,无花果有滋补、润肠、健脾、开胃、催乳等作用,鸡内金消食健胃,涩精止遗,消积滞,健脾胃,猴头菇具有健胃,补虚,抗癌,益肾精之功效,蒲公英有利尿、缓泻、退黄疸、利胆等功效,肉豆蔻有温中行气,涩肠止泻的作用,山药是传统补益中药材,含有多种对人体有益的营养物质和活性成分,对机体功能存在广泛的影响,有健脾养胃、补肺益肾、止泻利湿之功效;
本发明所述的药食两用中药提取物及新资源食品是指石斛、冬虫夏草(冬虫夏草菌丝体)、蛹虫草、菊芋、薏苡仁、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、甘草、香菇、陈皮、茯苓、黄精、木瓜、肉豆蔻、杏仁、覆盆子、马齿苋、砂仁、麦芽、桃仁、芡实其中的7种以上或全部,采用生物酶解或预水解SBE提取并微胶囊化,经喷雾干燥及冷冻干燥的提取物后的混合物。
2、短肽:即为低聚肽,是指利用生物酶工程技术从动物或植物蛋白中分离提取的一类小分子蛋白质,其平均分子量在1000Dalton以下,易溶于水,对酸、热稳定,可以不需经过消化而直接吸收,生物利用率高,在吸收和利用上优于游离的氨基酸和完整的蛋白质,可应用于蛋白质补充食品中,尤其对于消化吸收能力低下的人群,短肽是极佳的氮源,除营养功能外,短肽还具有一系列的生理活性功能:提高小肠的消化吸收功能, 增强机体免疫力,抗氧化, 辅助调节血糖,辅助调节血脂,辅助降血压,抗辐射, 促进矿物质吸收, 增强药食两用中草药中功能因子的作用效果;
本发明所述的短肽是指玉米低聚肽、小麦低聚肽、海洋胶原肽、海洋骨原肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽其中一种、几种或全部混合。
3、益生元: 以促益生菌肠道定植、肠道收敛、降低肠道pH环境,也不被大多数的肠道腐败菌利用,但可以促进人体内有益细菌——乳杆菌、双歧 杆菌的生长繁殖,从而可以抑制腐败菌生长,有助于改善和维持肠道正常功能;长期食用可以延缓衰老、通便、提高免疫力、减轻肝脏负担、提高营养素的吸收率,特别是能够改善机体对钙、铁、锌等金属离子 的吸收;可选择性地促进有益菌(双歧、乳酸)的生长繁殖外,还可代谢为酸性产物如乳酸等有机酸,使结肠内pH值降低,抑制肠道有害细菌的生长;使小肠内水电解质滞留在肠腔,产生高渗效果,刺激肠蠕动引起缓泻,从而促进肠道内毒素及其他毒性物质的排出,乳果糖还可直接灭活肠道中内毒素、降低肠道pH值,已广范应用于增强儿童抵抗力的治疗;
本发明所述的益生元为2类
a.对外源益生菌有很强的定植作用益生元:山药、薏仁、鸡内金、芡实、菊芋的提取物、水苏糖、酵母其中的几种或全部混合;
b.普通益生元:低聚异麦芽糖、低聚果糖、大豆低聚糖、低聚木糖其中的一种、几种或全部混合;
本是指低聚异麦芽糖、水苏糖、低聚果糖、大豆低聚糖、低聚木糖其中的一种、几种或全部混合。
4、氨基酸:分为必需氨基酸与非必需氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性;摄取适量的蛋氨酸有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用;亮氨酸能够修复肌肉,控制血糖,并给身体组织提供能量,必需氨基酸苯丙氨酸可以抑制癌瘤生长,又可以降低药物的毒副作用,赖氨酸可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育;精氨酸有助于将血液中的氨转变为尿素而排泄出去;对于高氨血症,肝脏机能障碍等均有功效;组氨酸降低胃液酸度,缓和胃肠手术的疼痛,减轻妊娠期呕吐及胃部灼热感,抑制由植物神经紧张而引起的消化道溃烂,对过敏性疾病,如哮喘等也有功效;色氨酸可以预防糙皮病、抑郁症,改善睡眠和调节情绪;
本发明所述的氨基酸是指L-谷氨酰胺、蛋氨酸、异亮氨酸、酪氨酸、苯丙氨酸、赖氨酸、精氨酸、组氨酸、色氨酸、瓜氨酸、鸟氨酸、牛磺酸其中的一种、几种或全部混合。
5、维生素和矿物质:
维生素和矿物质是人体必需的营养素,本发明中添加的维生素为维生素和矿物质是人体必需的营养素;
本发明中添加的维生素为维生素A、维生素D、维生素E、维生素K、维生素K1、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、维生素Be、维生素Bu、烟酸、叶酸、泛酸、胆碱、生物素其中的 一种、几种或全部混合;
本发明中添加的矿物质为钙、磷、钾、钠、镁、氯、铁、锌、硒、铜、锰、碘、氟、铬、钼其中的一种、几种或全部混合,本发明所述的矿物质添加为该矿物质的有机或无机化合物;
本发明中维生素矿物质的添加量参照GB14880《食品营养强化剂使用卫生标准》、GB2760《食品添加剂使用标准》执行,现以1000g成品为例,添加量为维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K0.0075g、维生素K10.00001g、维生素C10.625g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B0.0023g、维生素Be 、维生素Bu、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、氯、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g。
6、制备方法:先将石斛、薏苡仁、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、甘草、香菇、陈皮、黄精、木瓜、肉豆蔻、杏仁、覆盆子、马齿苋、砂仁、麦芽、芡实等中药或新资源食品的原料成分,按照所述重量份的配比加入上述物料,清洗、浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的益生元、短肽、益生菌、冬虫夏草(冬虫夏草菌丝体)、桃仁、蛹虫草、茯苓、菊芋、多种维生素及矿物质混合后进行巴氏灭菌1小时制成固体饮料、颗粒剂;也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥, 并不添加肉豆蔻、黑芝麻粉、菊芋粉,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在洁净干燥环境内进行。
本配方方便食品的特性及其对机体的作用主要表现在以下几个方面:
1、本发明是结合大肠癌患者的体质特征,综合当今美国哈佛大学的先进生理学、医药、营养学及临床应用等研究成果研制的,因人而异,黄金配伍。
2、本发明依据“消中寓补”、“均衡调养”的传统中医的精髓理论(肝、脾、肾三脏同调为主原则),采用多种药食两用的中药提取物精华、短肽为主要原料,以益生元、氨基酸、多种维生素及矿物质为辅料,各种配料的有机组合,将各种功能进行融合,并通过有效成分之间的协同作用,增强作用效果。
3、具有高效吸收性,利用本发明配方,各种组分采用适宜的比例搭配制备的食品,经一定量水溶解后呈等渗状态,能快速通过胃到达小肠,吸收快速、完全,可以迅速补充大肠癌患者所需营养。
4、本发明配方中采用各种药食两用中草药的提取物,含有多种功能活性成分,不仅提高了功能因子的浓度,减少各种杂质的摄入,有助于减轻肝肾负担,具有增强人体抵抗力的作用,还有起到行气散结、消积化瘀、利水消肿、清热解毒、理气化浊、降逆止呕以及增强免疫力的功效。
5. 本发明配方食品以多种来源的食源性生物活性短肽为氮源,因为短肽不需消化即可吸收,更有利于机体的利用,可以有效改善大肠癌患者的负氮平衡,而且食源性短肽能够改善肠粘膜上皮细胞的结构和功能,提高肠粘膜的吸收能力。
6、本发明配方中所含的益生元,通过促进肠内益生菌的生长繁殖,抑制腐败菌的生长,同时在肠粘膜表面形成一道保护屏障,可以抵御肠道腐败菌对肠粘 膜的损伤,减少肠内有害物质的吸收,还可以促进肠道蠕动,加速肠内残留物质的排出,可以防止便秘,而且通过促进肠道益生菌的生长繁殖也可以增强机体免疫力。
7、本发明配方中所含的氨基酸,是构成蛋白质的基本单位,赋予蛋白质特定的分子结构形态,使其具有生化活性,有助于人体内各种含硫化合物的代谢并且其所含的甲基对有毒物或药物进行甲基化而起到解毒的作用,能够修复肌肉,控制血糖,并给身体组织提供能量,还可提高食物蛋白质的吸收和利用,达到均衡营养,促进生长发育。
8、本发明配方食品含多种维生素和矿物质,可迅速补充大肠癌患者所需的微量营养素,短肽通过与钙、铁、锌等的螯合后,更增加了矿物质元素的吸收率。
9、本发明配方中不含脂肪和胆固醇,能够在补充蛋白质、微量营养素的同时,不会增加脂肪、胆固醇的摄入,避免了肉、蛋等髙蛋白食物的不利影响。
具体实施方式
下面通过以下实施例对本发明作进一步说明,它将有助于理解本发明。
实施例一
实现本发明目的大肠癌患者食用的方便食品是以结合大肠癌患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以7种以上药食两用的中药提取物精华、短肽为主要原料,以益生元、氨基酸、多种维生素、多种矿物质为辅料制成的食品;
按下列原料及其用量进行配方:药食两用的提取物: 石斛16g、冬虫夏草(冬虫夏草菌丝体)16g、蛹虫草14g、菊芋14g、薏苡仁14g、山药14g、蒲公英14g、山楂12g、无花果12g、金银花12g、鸡内金10g、猴头菇10g、沙棘10g、佛手10g、枸杞10g、莱菔子10g、甘草10g、香菇8g、陈皮8g、茯苓8g、黄精8g、木瓜8g、肉豆蔻8g、杏仁8g、覆盆子6g、马齿苋6g、砂仁6g、麦芽6g、桃仁6g、芡实6g、短肽300g、益生元250g、氨基酸100g、维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K0.0075g、维生素K10.00001g、维生素C10.625g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B0.0023g、维生素Be 、维生素Bu、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、氯、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g;
制作时先将石斛、薏苡仁、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、甘草、香菇、陈皮、黄精、木瓜、肉豆蔻、杏仁、覆盆子、马齿苋、砂仁、麦芽、芡实等中药或新资源食品的原料成分,按照所述重量份的配比加入上述物料,清洗、浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的益生元、短肽、益生菌、冬虫夏草(冬虫夏草菌丝体)、桃仁、蛹虫草、茯苓、菊芋、多种维生素及矿物质混合后进行巴氏灭菌1小时制成固体饮料、颗粒剂;也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥, 并不添加肉豆蔻、黑芝麻粉、菊芋粉,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在洁净干燥环境内进行。
实施案例二
上述调理大肠癌的方便食品还包括以重量计的下列组分:药食两用的提取物: 石斛16g、蛹虫草16g、菊芋16g、薏苡仁16g、山药16g、蒲公英16g、山楂14g、无花果14g、金银花14g、鸡内金14g、猴头菇14g、沙棘12g、佛手12g、枸杞12g、莱菔子12g、甘草12g、香菇10g、陈皮10g、茯苓10g、黄精10g、木瓜10g、肉豆蔻8g、覆盆子8g、马齿苋8g、氨基酸100g、短肽300g、益生元250g、多种维生素及矿物质50g。
实施案例三
上述调理大肠癌的方便食品还包括以重量计的下列组分:药食两用的提取物: 石斛18g、蛹虫草18g、菊芋18g、薏苡仁18g、山药16g、蒲公英16g、山楂16g、无花果16g、金银花16g、鸡内金16g、沙棘14g、佛手14g、枸杞14g、莱菔子14g、甘草14g、香菇14g、黄精12g、木瓜12g、肉豆蔻12g、覆盆子12g、氨基酸100g、短肽300g、益生元250g、多种维生素及矿物质50g。
本发明以微胶囊、生物酶解、预水解SBE及喷雾干燥集成创新,构成的产业化生产的关键技术,按以上微胶囊、生物酶解、预水解SBE及喷雾干燥集成创新工艺制成方便食品、固体饮料、颗粒剂或胶囊剂或压制成型的片剂、软胶囊。
Claims (8)
1.一种调理大肠癌的方便食品,其特征是以结合大肠癌患者的体质特征,依据传统中医的精髓理论,因人而异,黄金配伍以7种以上药食两用的中药提取物精华、短肽为主要原料,以益生元、多种维生素、氨基酸、多种矿物质为辅料制成的食品;
按下列原料及其用量进行配方:药食两用的提取物: 石斛16g、冬虫夏草(冬虫夏草菌丝体)16g、蛹虫草14g、菊芋14g、薏苡仁14g、山药14g、蒲公英14g、山楂12g、无花果12g、金银花12g、鸡内金10g、猴头菇10g、沙棘10g、佛手10g、枸杞10g、莱菔子10g、甘草10g、香菇8g、陈皮8g、茯苓8g、黄精8g、木瓜8g、肉豆蔻8g、杏仁8g、覆盆子6g、马齿苋6g、砂仁6g、麦芽6g、桃仁6g、芡实6g、短肽300g、益生元250g、氨基酸100g、维生素A0.01g、维生素D0.000015g、维生素E0.12g、维生素K0.0075g、维生素K10.00001g、维生素C10.625g、维生素B10.016g、维生素B20.016g、维生素B60.015g、维生素B0.0023g、维生素Be 、维生素Bu、烟酸0.2g、叶酸0.003g、泛酸0.051g、胆碱2.5g、生物素0.000057g、钙6.2g、磷4.5g、钾10g、钠16.17g、镁1.7g、氯、铁0.15g、锌6.2g、硒0.00012g、铜0.007g、锰0.018g、碘0.00001g、氟0.00001g、铬0.00001g、钼0.00001g;
制作时先将石斛、薏苡仁、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、甘草、香菇、陈皮、黄精、木瓜、肉豆蔻、杏仁、覆盆子、马齿苋、砂仁、麦芽、芡实等中药或新资源食品的原料成分,按照所述重量份的配比加入上述物料,清洗、浸泡后加入β-环状糊精,用预水解SBE技术提取后,经喷雾干燥而制备的粉状物质,再添加生物酶解提取的益生元、短肽、益生菌、冬虫夏草(冬虫夏草菌丝体)、桃仁、蛹虫草、茯苓、菊芋、多种维生素及矿物质混合后进行巴氏灭菌1小时制成固体饮料、颗粒剂;也可以加入适量附料制成胶囊、片剂或加入甜味剂和黑芝麻粉制成饼干等快速、方便食品便于外出携带食用,若做成饮料则省去经喷雾干燥, 并不添加肉豆蔻、黑芝麻粉、菊芋粉,分装成10-65ml/瓶,每日早、中、晚饭后0.5小时各饮1瓶,所有操作均在洁净干燥环境内进行。
2.根据权利要求 1所述的调理大肠癌的方便食品,其特征是所述的药食两用中草药提取物及新资源食品是指石斛、冬虫夏草(冬虫夏草菌丝体)、蛹虫草、菊芋、薏苡仁、山药、蒲公英、山楂、无花果、金银花、鸡内金、猴头菇、沙棘、佛手、枸杞、莱菔子、甘草、香菇、陈皮、茯苓、黄精、木瓜、肉豆蔻、杏仁、覆盆子、马齿苋、砂仁、麦芽、桃仁、芡实其中的7种以上或全部混合。
3.根据权利要求 1所述的调理大肠癌的方便食品,其特征在于按照所述配方混合可制备成粉状、颗粒状、胶囊状、片剂状、饮料类食品。
4.根据权利要求 1所述的调理大肠癌的方便食品,其特征是所述的益生元为.对外源益生菌有很强的定植作用益生元为山药、薏仁、鸡内金、芡实、菊芋的提取物、水苏糖、酵母及普通益生元其中的几种或全部混合。
5.根据权利要求 1所述的调理大肠癌的方便食品,其特征在于它包括以下关键技术 :以微胶囊、生物酶解、预水解SBE及喷雾干燥集成创新,构成的产业化生产的关键技术,按以上微胶囊、生物酶解、预水解SBE及喷雾干燥集成创新工艺制成方便食品、固体饮料、颗粒剂或胶囊剂或压制成型的片剂、软胶囊。
6.根据权利要求1所述的调理大肠癌的方便食品,其特征是所述的维生素为维生素A、维生素D、维生素E、维生素K、维生素K1、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、维生素Be、维生素Bu、烟酸、叶酸、泛酸、胆碱、生物素其中的一种、几种或全部混合;所述的矿物质为钙、磷、 钾、钠、镁、氯、铁、锌、硒、铜、锰、碘、氟、铬、钼其中的一种、几种或全部混合。
7.根据权利要求1所述的调理大肠癌的方便食品,其特征是所述的短肽为海洋胶原肽、玉米低聚肽、小麦低聚肽、海洋骨原肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽其中一种、几种或全部混合。
8.根据权利要求1所述的调理大肠癌的方便食品,其特征是所述的氨基酸为L-谷氨酰胺、蛋氨酸、异亮氨酸、酪氨酸、苯丙氨酸、赖氨酸、精氨酸、组氨酸、色氨酸、瓜氨酸、鸟氨酸、牛磺酸其中的一种、几种或全部混合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410417229.5A CN104187725A (zh) | 2014-08-23 | 2014-08-23 | 一种调理大肠肿瘤的方便食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410417229.5A CN104187725A (zh) | 2014-08-23 | 2014-08-23 | 一种调理大肠肿瘤的方便食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104187725A true CN104187725A (zh) | 2014-12-10 |
Family
ID=52073240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410417229.5A Pending CN104187725A (zh) | 2014-08-23 | 2014-08-23 | 一种调理大肠肿瘤的方便食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104187725A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105831753A (zh) * | 2016-04-20 | 2016-08-10 | 湖南康瑞琦生物科技有限公司 | 供肿瘤患者食用的特殊医学用途配方食品及其制备方法 |
| CN110468175A (zh) * | 2019-08-22 | 2019-11-19 | 赵秋萍 | 一种复合植物肽粉及其制备方法和用途 |
-
2014
- 2014-08-23 CN CN201410417229.5A patent/CN104187725A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105831753A (zh) * | 2016-04-20 | 2016-08-10 | 湖南康瑞琦生物科技有限公司 | 供肿瘤患者食用的特殊医学用途配方食品及其制备方法 |
| CN110468175A (zh) * | 2019-08-22 | 2019-11-19 | 赵秋萍 | 一种复合植物肽粉及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104187611A (zh) | 胃肠道吸收障碍全营养配方食品 | |
| CN104855967A (zh) | 肥胖、减脂手术非全营养配方食品 | |
| CN104172186A (zh) | 一种调理肝肿瘤的方便食品 | |
| CN104223057A (zh) | 肝病全营养配方食品 | |
| CN104839707A (zh) | 阴虚体质非全营养配方食品 | |
| CN104886552A (zh) | 慢性胃炎非全营养配方食品 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN104256648A (zh) | 甲状腺癌全营养配方食品 | |
| CN105029400A (zh) | 类风湿关节炎医学配方食品 | |
| CN104323240A (zh) | 大肠癌全营养配方食品 | |
| CN104323246A (zh) | 食管癌全营养配方食品 | |
| CN104187666A (zh) | 一种调理阴茎癌的方便食品 | |
| CN104161266A (zh) | 脾胃虚寒全营养配方食品 | |
| CN104839666A (zh) | 前列腺炎医学配方食品 | |
| CN104187667A (zh) | 一种调理胃癌的方便食品 | |
| CN104856002A (zh) | 痰湿体质非全营养配方食品 | |
| CN104856008A (zh) | 萎缩性胃炎非全营养配方食品 | |
| CN104839645A (zh) | 肾癌医学配方食品 | |
| CN104323278A (zh) | 肝癌全营养配方食品 | |
| CN104187725A (zh) | 一种调理大肠肿瘤的方便食品 | |
| CN104146266A (zh) | 调理黄褐斑的全营养配方食品 | |
| CN104187650A (zh) | 特禀体质全营养配方食品 | |
| CN104082718A (zh) | 一种大肠肿瘤患者食用的微生态特殊膳食 | |
| CN104187662A (zh) | 一种调理卵巢癌的方便食品 | |
| CN104187661A (zh) | 一种调理肺癌的方便食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |
|
| WD01 | Invention patent application deemed withdrawn after publication |